Hana Pharm Co., Ltd. Statistics
Want to see KR:293480 full AI Analyst Report?
Hana Pharm Co., Ltd. (293480) Stock Statistics & Valuation Metrics
Total Valuation
Hana Pharm Co., Ltd. has a market cap or net worth of KRW 142.89B. The enterprise value is KRW 207.31B.
- Market Cap
- KRW 142.89B
- Enterprise Value
- KRW 207.31B
Share Statistics
Hana Pharm Co., Ltd. has 17,772,945 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 17,772,945
- Owned by Insiders
- ―
- Owned by Institutions
- 0.18%
Financial Efficiency
Hana Pharm Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.20%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 3.20%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 328.09M
- Profits Per Employee
- 12.02M
- Employee Count
- 730
- Asset Turnover
- 0.57
- Inventory Turnover
- 1.60
Valuation Ratios
The current PE Ratio of Hana Pharm Co., Ltd. is 8.35. Hana Pharm Co., Ltd.’s PEG ratio is -0.57.
- PE Ratio
- 8.35
- PS Ratio
- 0.59
- PB Ratio
- 0.44
- Price to FCF
- -2.75
- Price to Operating Cash Flow
- 8.86
- PEG Ratio
- -0.57
Income Statement
In the last 12 months, Hana Pharm Co., Ltd. had revenue of 239.50B and earned 8.78B in profits. Earnings per share was 507.00.
- Revenue
- 239.50B
- Gross Profit
- 146.39B
- Operating Income
- 25.92B
- Pretax Income
- 18.38B
- Net Income
- 8.78B
- EBITDA
- 36.95B
- Earnings Per Share (EPS)
- 507.00
Cash Flow
In the last 12 months, operating cash flow was 16.43B and capital expenditures -69.42B, giving a free cash flow of -52.99B billion.
- Operating Cash Flow
- 16.43B
- Free Cash Flow
- -52.99B
- Free Cash Flow per Share
- -2989.98
Dividends & Yields
Hana Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 3.17%
- Dividend Per Share
- ―
- Dividend Yield
- 3.17%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -36.46%
- Earnings Yield
- 12.02%
Stock Price Statistics
- Beta
- 0.07
- 52-Week Price Change
- -28.13%
- 50-Day Moving Average
- 8311.80
- 200-Day Moving Average
- 9103.35
- Relative Strength Index (RSI)
- 50.86
- Average Volume (3m)
- 20.75K
Important Dates
Hana Pharm Co., Ltd. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Hana Pharm Co., Ltd. as a current ratio of 1.84, with Debt / Equity ratio of 18.74%
- Current Ratio
- 1.84
- Quick Ratio
- 0.93
- Debt to Market Cap
- 0.28
- Net Debt to EBITDA
- 1.32
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Hana Pharm Co., Ltd. has paid 9.55B in taxes.
- Income Tax
- 9.55B
- Effective Tax Rate
- 0.52
Enterprise Valuation
Hana Pharm Co., Ltd. EV to EBITDA ratio is 4.85, with an EV/FCF ratio of -3.81.
- EV to Sales
- 0.82
- EV to EBITDA
- 4.85
- EV to Free Cash Flow
- -3.81
- EV to Operating Cash Flow
- 12.28
Balance Sheet
Hana Pharm Co., Ltd. has KRW 17.28B in cash and marketable securities with KRW 68.84B in debt, giving a net cash position of -KRW 51.56B billion.
- Cash & Marketable Securities
- KRW 17.28B
- Total Debt
- KRW 68.84B
- Net Cash
- -KRW 51.56B
- Net Cash Per Share
- -KRW 2,900.94
- Tangible Book Value Per Share
- KRW 17.68K
Margins
Gross margin is 61.46%, with operating margin of 11.56%, and net profit margin of 7.06%.
- Gross Margin
- 61.46%
- Operating Margin
- 11.56%
- Pretax Margin
- 11.34%
- Net Profit Margin
- 7.06%
- EBITDA Margin
- 16.82%
- EBIT Margin
- 11.56%
Analyst Forecast
The average price target for Hana Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 7.46%
- EPS Growth Forecast
- -14.42%
Scores
- Smart Score
- ―
- AI Score
- 60
